Sorrento Therapeutics Inc (NASDAQ: SRNE) today broadcasted the conclusion of registration for its Phase 2 scientific pilot of Abivertinib in hospitalized COVID-19 patients in Brazil. This learning conclusion trails the lately finished registration of the U.S. Phase 2 scientific pilot. Statistics from the study is estimated to be accessible for […]
Tag: COVID-19
Histogen Inc. (NASDAQ: HSTO) Jumps 16% After Releasing Promising Phase 1 Emricasan Study Results in COVID-19
Histogen Inc. (NASDAQ: HSTO) jumped 16.16% after the company and Amerimune LLC, its partner, announced the top-line resulted from the phase 1 study assessing emricasan’s safety, preliminary efficacy, and tolerability in the treatment of patients with mild symptomatic COVID-19. Emricasan shows favorable safety and tolerability profile. Compared to placebo, emricasan […]
Edesa Biotech Inc (NASDAQ: EDSA) proclaims Hopeful Assessment of COVID-19 Review
Edesa Biotech Inc (NASDAQ: EDSA), a pharmaceutical corporation, today indicated that an autonomous Data and Safety Monitoring Board (DSMB) had finalized a preponderant assessment of the business’s COVID-19 medication applicant. The appraisal founded on blinded proportional statistics has suggested that the company’s global revision continue as intended. The safety monitoring […]
Enochian Biosciences Inc (NASDAQ: ENOB) Soaring on an Exclusive License for Coronavirus Treatment
Enochian Biosciences Inc (NASDAQ: ENOB) was up 1.21% on Monday, and its shares were valued at $5.87. Last week when the company had announced that the U.S. FDA had given its nod for HIV’s “potential functional cure” drug, the investors rejoiced and pushed the stock. On June 14, the shares […]
Aethlon Medical Inc. (NASDAQ: AEMD) Drops 36% After Announcing $12 Million Direct Offering
Aethlon Medical Inc. (NASDAQ: AEMD) plunged 36.05% after announcing the signing of a definitive agreement with an institutional investor to acquire 1,380,555 of its common shares in a registered direct offering at $9 per share priced at-the-market. Aethlon closes a $12 million direct offering. The company anticipates closing the direct […]
Precipio Inc (NASDAQ: PRPO) Revives Back To Life After Sorrowful 2020
Precipio Inc (NASDAQ: PRPO) is trading at $3.80 at the time of this write-up, up 15.50% over past 5 trading session. Around 29.91 millions shares traded in yesterday’s trading session. Once considered dead, the specialty diagnostics company has shown some huge signs of life. In April 2020, the stock had […]
Why Is Sundial Growers Inc. (NASDAQ: SNDL) Rising With Other Popular Pot Stocks?
Sundial Growers Inc. (NASDAQ: SNDL) stock was 15% up on Friday, as investors remain hopeful for its deal-making with Inner Spirit Holdings. The balance sheet of Sundial Growers reflects a positive horizon, indicating that there could be some more acquisitions in the following months. The company’s deal-making prospects is appealing […]
Netflix Inc. (NASDAQ:NFLX) Added 8.51 Million New Paying Subscribers In Q4 2020
Netflix Inc. (NASDAQ:NFLX) added 8.5 million more paying subscribers in Q4 2020 to take its total paying subscribers past 200 million. Netflix tops analysts’ new subscriber estimates in Q4 Despite growth slowing as the pandemic eases, the streaming giant managed to top Wall Street estimates of 6.03 million subscribers in […]
Facebook Launches Forecast App For Predictions On Global Events
Despite its unpopularity when it comes to reliable information or balanced discussions, Facebook Inc. (NASDAQ:FB) is going on with the launch of its prediction app, Forecast. The app permits collective insights and crowdsourced predictions, which will help in shaping conversations. Facebook launches Forecast app The company is launching Forecast to […]